Patent application number | Description | Published |
20090268241 | METHOD OF CONTROLLING A PRINT JOB AND A TERMINAL DEVICE USING THE SAME - A method of controlling a print job using a universal print driver of a terminal device connectable to a plurality of image forming apparatuses. The method can include selecting one of the plurality of image forming apparatuses, selecting pre-stored printing options of the plurality of image forming apparatuses, determining whether the pre-stored printing options are available on the image forming apparatus for which the universal print driver is selected, and displaying that the pre-stored printing option is unavailable, if at least one of the pre-stored printing options is unavailable. Therefore, a user can easily recognize information regarding unavailable pre-stored printing options. | 10-29-2009 |
20100073693 | METHOD OF CONTROLLING SCALED-DOWN PRINTING FOR HOST DEVICE AND THE HOSE DEVICE USING THE METHOD - A method of controlling scaled-down (size-reduced) printing for a host device and the host device using the method, the method including inputting a scaling-down mode for the print document through a user interface (UI) of the host device; inputting a scaling-down rate fine adjustment for the scaling-down mode to generate a new scaling-down rate; and applying the new scaling-down rate to the print document. Thus, a user is provided with the convenience of obtaining a scaled-down print result that is not distorted. | 03-25-2010 |
20100160617 | NUCLEASE-RESISTANT RNA APTAMER INHIBITING REPLICATION OF HEPATITIS C VIRUS REPLICON - Disclosed a nuclease-resistant RNA aptamer for inhibiting the replication of HCV replicon. This aptamer is capable of binding specifically to HCV NS5B and inhibiting the proliferation of the HCV replicon, and is composed of at least one sequence selected from a group consisting of SEQ ID NOS. 1 to 4, in which a fluoro group is substituted for 2′-hydroxy of both U (uracil) and C (cytosine) bases, and SEQ ID NO. 4, which is tagged with a cholesteryl group at a 5′ end and with idT at a 3′ end. The RNA aptamer is useful in the diagnosis and treatment of HCV infection. | 06-24-2010 |
20110012163 | DEVICE HAVING A MULTILAYERED STRUCTURE AND METHOD OF FABRICATING THEREOF - The invention provides a multilayered device and the method for fabricating the same. The multilayered device comprises a substrate, a first layer deposited on the substrate, a second layer deposited on the first layer, and a third layer deposited on the second layer. The coverage of the second layer is determined by a rate of crystallization of the third layer. The rate of crystallization of the third layer is determined by measuring X-ray diffraction of the device. | 01-20-2011 |
20130017975 | SINGLE NUCLEOTIDE POLYMORPHISM FOR PREDICTING PROGNOSIS OF HEPATOCELLULAR CARCINOMAAANM Chung; Young HwaAACI SeoulAACO KRAAGP Chung; Young Hwa Seoul KRAANM Park; Neung HwaAACI UlsanAACO KRAAGP Park; Neung Hwa Ulsan KRAANM Yu; Eun SilAACI SeoulAACO KRAAGP Yu; Eun Sil Seoul KRAANM Lee; Young-JooAACI SeoulAACO KRAAGP Lee; Young-Joo Seoul KRAANM Kim; Jeong AAACI SeoulAACO KRAAGP Kim; Jeong A Seoul KRAANM Lee; Dan-BiAACI SeoulAACO KRAAGP Lee; Dan-Bi Seoul KRAANM Lee; Sae-HwanAACI Cheonan-shiAACO KRAAGP Lee; Sae-Hwan Cheonan-shi KRAANM Lee; Jong-EunAACI SeoulAACO KRAAGP Lee; Jong-Eun Seoul KR - Single nucleotide polymorphisms (SNP) for predicting prognosis of hepatocellular carcinoma after curative surgical resection are provided. The SNPs have a significant correlation with an over-expression of MTA1 which is useful prognostic factor for prediction of prognosis or poor survival after curative surgical resection of hepatocellular carcinoma. Therefore, the SNPs can be used in developing micro-arrays or test kits for prediction of the prognosis of hepatocellular carcinoma, and in screening drugs to improve poor prognosis of hepatocellular carcinoma after curative surgical resection. | 01-17-2013 |
20130023442 | SINGLE NUCLEOTIDE POLYMORPHISM FOR PREDICTING RECURRENCE OF HEPATOCELLULAR CARCINOMA - Single nucleotide polymorphisms (SNP) for predicting recurrence of hepatocellular carcinoma after curative surgical resection are provided. The SNPs have a significant correlation with higher risk of hepatocellular carcinoma recurrence after curative surgical resection. Therefore, the SNPs can be used in developing micro-arrays or test kits for predicting recurrence of hepatocellular carcinoma, and in screening drugs to prevent recurrence of hepatocellular carcinoma after curative surgical resection. | 01-24-2013 |
20140212110 | APPARATUS AND METHOD FOR DISPLAYING IMAGES - Disclosed herein is an image display apparatus including a storage unit storing a plurality of images, an input unit receiving a selection command for selecting one or more images from among the plurality of images, and a display unit displaying at least one image of the selected images in a first zone and at least one second image of the selected images in a second zone. | 07-31-2014 |
20150259646 | Methods for Isolating and Proliferating Autologous Cancer AntiGen-Specific CD8+ T Cells - Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8 | 09-17-2015 |